These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36588288)

  • 1. Venous Thromboembolism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-analysis.
    Goualou M; Noumegni S; de Moreuil C; Le Guillou M; De Coninck G; Hoffmann C; Robin S; Morcel K; Le Moigne E; Tremouilhac C; Merviel P; Le Mao R; Leroyer C; Bouée S; Couturaud F; Tromeur C
    Thromb Haemost; 2023 Mar; 123(3):283-294. PubMed ID: 36588288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis.
    Wormer KC; Jangda AA; El Sayed FA; Stewart KI; Mumford SL; Segars JH
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():117-124. PubMed ID: 29602141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolism and in vitro fertilization - a systematic review.
    Sennström M; Rova K; Hellgren M; Hjertberg R; Nord E; Thurn L; Lindqvist PG
    Acta Obstet Gynecol Scand; 2017 Sep; 96(9):1045-1052. PubMed ID: 28382684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
    Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    Tang H; Mourad S; Zhai SD; Hart RJ
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008605. PubMed ID: 27901279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial and venous complications after fertility treatment: A French nationwide cohort study.
    Filipovic-Pierucci A; Gabet A; Deneux-Tharaux C; Plu-Bureau G; Olié V
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():57-63. PubMed ID: 31009860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.
    Lambalk CB; Banga FR; Huirne JA; Toftager M; Pinborg A; Homburg R; van der Veen F; van Wely M
    Hum Reprod Update; 2017 Sep; 23(5):560-579. PubMed ID: 28903472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles.
    Rova K; Passmark H; Lindqvist PG
    Fertil Steril; 2012 Jan; 97(1):95-100. PubMed ID: 22118992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cabergoline for preventing ovarian hyperstimulation syndrome.
    Tang H; Hunter T; Hu Y; Zhai SD; Sheng X; Hart RJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008605. PubMed ID: 22336848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures.
    Huang X; Wang P; Tal R; Lv F; Li Y; Zhang X
    Int J Gynaecol Obstet; 2015 Nov; 131(2):111-6. PubMed ID: 26304048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume expanders for the prevention of ovarian hyperstimulation syndrome.
    Youssef MA; Mourad S
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001302. PubMed ID: 27577848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
    Siristatidis CS; Maheshwari A; Vaidakis D; Bhattacharya S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006606. PubMed ID: 30480769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of thromboembolism in relation to in vitro fertilization.
    Lattová V; Dostál J; Vodička J; Procházka M
    Ceska Gynekol; 2019; 84(3):229-232. PubMed ID: 31324115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome.
    Luke B; Brown MB; Morbeck DE; Hudson SB; Coddington CC; Stern JE
    Fertil Steril; 2010 Sep; 94(4):1399-1404. PubMed ID: 19591989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso NN; Hassan R
    Cochrane Database Syst Rev; 2017 May; 5(5):CD002811. PubMed ID: 28535578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
    Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
    Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.